OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.500
+0.280 (6.64%)
At close: Jun 26, 2026, 4:00 PM EDT
4.530
+0.030 (0.67%)
After-hours: Jun 26, 2026, 7:43 PM EDT
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OnKure Therapeutics stock have an average target of 24.33, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 440.67% from the current stock price of 4.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OnKure Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $30 | Buy | Maintains | $30 | +566.67% | Jun 24, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +255.56% | May 10, 2026 |
| JonesTrading | JonesTrading | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $34 → $27 | Buy | Maintains | $34 → $27 | +500.00% | Mar 16, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jan 27, 2026 |
Financial Forecast
Revenue This Year
375.00K
Revenue Next Year
666.67K
from 375.00K
Increased by 77.78%
EPS This Year
-2.50
from -4.40
EPS Next Year
-2.13
from -2.50
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5M | 2.0M | |
| Avg | 375,000 | 666,670 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 433.3% | 200.0% |
| Avg | 77.8% | - |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.92 | -1.86 | |
| Avg | -2.50 | -2.13 | |
| Low | -3.19 | -2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.